Frontlight ResearchEarly access
Trial site
Velocity Nova Sp. z o.o.
- 12running trials
- 7closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes8 trials
- Obesity5 trials
- Heart failure3 trials
- Alzheimer disease1 trial
- Ankylosing spondylitis1 trial
- Chronic kidney disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- High blood pressure1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 316 trials
- Phase 22 trials
- Phase 2/31 trial
- Status
- Recruiting8 trials
- Completed7 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Lead sponsor
- Novo Nordisk A/S9 trials
- Boehringer Ingelheim4 trials
- Ascletis Pharma (China) Co. Ltd.2 trials
- Alfasigma S.p.A.1 trial
- Exciva GmbH1 trial
- and 2 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
Active, not recruiting
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity4 recruiting
- Heart failure3 recruiting
- Type 2 diabetes3 recruiting
- Alzheimer disease1 recruiting
- High blood pressure1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 14 Nov 2026